International Course on Antibiotics and Resistance ICARe, 11-19 Nov 2017

Dear All:

FYI, see below an announcement of an 8-day intensive course in Paris in November 2017: “ICARe is designed for early career scientists – assistant professors, new industry scientists, MDs, and postdoctoral research associates – as well as members from developing areas contending with the practical challenge of managing the antibiotic resistance problem with limited resources. Attendance will be limited to 40 students and will reflect the global nature of the problem.”

Also keep in mind the 6-8 Sep ASM-ESCMID conference in Boston on antibacterial drug development along with its preceding co-sponsored (CARB-X + ASM-ESCMID) workshop. 

–jr

John H. Rex, MD | Chief Medical Officer, F2G Ltd. | Chief Strategy Officer, CARB-X | Expert-in-Residence, Wellcome Trust
Follow me on Twitter: @JohnRex_NewAbx


Dear Colleague,

We are organizing the second edition of the International Course on Antibiotics and Resistance (ICARe) which will be held at the Fondation Mérieux, Annecy, France, November 11-19, 2017 (download flyer and course outline here).

The specific goal of ICARe is to bring leaders in academics and industry together with trained scientists at the dawn of their careers. Cutting-edge approaches for understanding and detection of resistance, antibiotic discovery, chemical optimization, and use of strategies that minimize the development of resistance will be examined.

Our course aims at providing future leaders in the field of antibiotics and resistance with the information they do not usually get in graduate or medical school, but that they need to make a serious contribution to solving the problem. In the past, they would receive some of that training once they joined a well-established antibiotic discovery program in pharma.  But more of the needed discoveries now rely on academic researchers with little or no experience, and many are spinning out biotech ideas without really understanding the challenges.

You can use the flyer to advertise for the course and the outline is to incite you to send your most promising collaborators.

Thank you in advance for your help,

P. Courvalin, M. Gilmore, G. Wright

Share

Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on whatsapp
Share on reddit

WAAW: Impact investing, podcasts, reports, and logos!

Dear All, Today we have a bit of a potpourri for WAAW (World Antibiotic Awareness Week). Lots of good stuff… In the new meetings category, we have two meetings for investors seeking social impact: 23 Nov 2020 (online, 6-7p CET): Webinar sponsored by Access to Medicine Foundation (ATM) entitled “The Materiality of Superbugs: Investor Action

COVID-19 and the Long-Term Trajectory of AMR Efforts: Wellcome Trust Deep Dive

Dear All (Wonkish alert! Coffee-up!), Today we have something special: A deep-dive into the future trajectory of AMR-related work developed by Wellcome Trust. The newly released report is here and there is a webinar discussing the report on Wednesday of this week (1500-16:00 GMT on 18 Nov 2020, go here to register). The back story

Global AMR Hub (Berlin) seeks Scientific Program Officer

Dear All, The G20’s Global AMR R&D Hub (https://globalamrhub.org/, see below my signature for a brief history of the Hub) has a job opening from 1 Feb 2021 for a Scientific Program Officer. Here’s a brief description of the role:  Contributes expert knowledge on AMR R&D to the further development of the Dynamic Dashboard and to

Scroll to Top